Oncogenomics

Announcement: OncoGenomics Achieves Landmark Milestone in Paternity Testing with Illumina FGx ForenSeq Platform

We are thrilled to announce that OncoGenomics has successfully conducted the first-ever paternity test in Lagos, Nigeria, utilizing the cutting-edge Illumina FGx ForenSeq Next-Generation Sequencing (NGS) platform. This achievement marks a historic milestone, making OncoGenomics the first in West Africa to leverage NGS technology for paternity testing.

The use of the Illumina FGx ForenSeq platform not only sets a new standard in forensic testing but also offers unmatched precision, reliability, and efficiency in paternity testing. By establishing this advanced testing capability locally, OncoGenomics is proud to provide accurate, timely results without the need for samples to be sent abroad—revolutionizing accessibility to advanced forensic services in Nigeria and across West Africa.

This breakthrough underscores our commitment to innovation and our dedication to empowering individuals with the most reliable forensic solutions right here in Nigeria. Thank you to our talented team and partners who made this possible. Together, we are pioneering a new era of genetic testing in West Africa.